Last updated: 11/07/2018 17:54:55

An Extended, Stratified Follow-on Study In Paediatric Subjects With Chronic Hepatitis B Who Have Completed Previous Lamivudine Studies

GSK study ID
NUC30926
Clinicaltrials.gov ID
Not applicable
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Study complete
Study complete
Overview
Eligibility
Locations
Study documents
Results summary
Plain language summaries
Additional information

Trial overview

Official title: An Extended, Stratified Follow-on Study In Paediatric Subjects With Chronic Hepatitis B Who Have Completed Previous Lamivudine Studies
Trial description: An Extended, Stratified Follow-on Study In Paediatric Subjects With Chronic Hepatitis B Who Have Completed Previous Lamivudine Studies
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:
Not applicable
Secondary outcomes:
Not applicable
Interventions:
Not applicable
Enrollment:
Not applicable
Primary completion date:
Not applicable
Observational study model:
Not applicable
Time perspective:
Not applicable
Clinical publications:
AN EXTENDED, STRATIFIED, FOLLOW-ON STUDY IN CHILDREN WITH CHRONIC HEPATITIS B (CHB) WHO HAVE COMPLETED PREVIOUS LAMIVUDINE STUDIES.. Etienne M. Sokal, Jacek Mizerski Poland Marek Woynarowski Wojciech Sluzewski Isabel B. Badia Deirdre A. Kelly Kathleen B. Schwarz Jorge A. Areias Nancy Little Stephen Gardner Mary Castiglia Maureen M. Jonas, 54th Annual Meeting of the American Association for the Study of Liver Diseases, Boston, MA; USA, 10/24/2003
Medical condition
Hepatitis B, Chronic
Product
lamivudine
Collaborators
Not applicable
Study date(s)
September 1999 to January 2003
Type
Not applicable
Phase
3

Participation criteria

Sex
Not applicable
Age
Not applicable
Accepts healthy volunteers
Not applicable

Trial location(s)

This study does not involve prospective enrollment of participants.

Study documents

Clinical study report
Available language(s): English
Scientific result summary
Available language(s): English

If you wish to request for full study report, please contact - [email protected]

Results overview

Not applicable

Recruitment status
Study complete
Actual primary completion date
Not applicable
Actual study completion date
2003-15-01

Plain language summaries

Plain language summaries of clinical trial results for Phase 2-4 clinical trials that were initiated on or after January 2022 will be posted by GSK within one year following study completion.

Additional information about the trial

Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website